Biofrontera Non Current Liabilities Total from 2010 to 2025

BFRIW Stock  USD 0.06  0.00  0.00%   
Biofrontera Warrants Non Current Liabilities Total yearly trend continues to be fairly stable with very little volatility. Non Current Liabilities Total will likely drop to about 4.3 M in 2025. During the period from 2010 to 2025, Biofrontera Warrants Non Current Liabilities Total regression line of quarterly data had mean square error of 110.1 T and geometric mean of  24,097,037. View All Fundamentals
 
Non Current Liabilities Total  
First Reported
2010-12-31
Previous Quarter
4.5 M
Current Value
4.3 M
Quarterly Volatility
19.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Biofrontera Warrants financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biofrontera Warrants' main balance sheet or income statement drivers, such as Tax Provision of 33 K, Interest Income of 202.9 K or Depreciation And Amortization of 1.5 M, as well as many indicators such as Price To Sales Ratio of 0.14, Dividend Yield of 0.0 or PTB Ratio of 0.98. Biofrontera financial statements analysis is a perfect complement when working with Biofrontera Warrants Valuation or Volatility modules.
  
Check out the analysis of Biofrontera Warrants Correlation against competitors.
For more information on how to buy Biofrontera Stock please use our How to Invest in Biofrontera Warrants guide.

Latest Biofrontera Warrants' Non Current Liabilities Total Growth Pattern

Below is the plot of the Non Current Liabilities Total of Biofrontera Warrants over the last few years. It is Biofrontera Warrants' Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biofrontera Warrants' overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Total10 Years Trend
Slightly volatile
   Non Current Liabilities Total   
       Timeline  

Biofrontera Non Current Liabilities Total Regression Statistics

Arithmetic Mean33,365,719
Geometric Mean24,097,037
Coefficient Of Variation57.58
Mean Deviation17,279,101
Median47,189,000
Standard Deviation19,213,371
Sample Variance369.2T
Range42.9M
R-Value(0.85)
Mean Square Error110.1T
R-Squared0.72
Significance0.000031
Slope(3,428,146)
Total Sum of Squares5537.3T

Biofrontera Non Current Liabilities Total History

20254.3 M
20244.5 M
20235.1 M
20226.1 M
202128 M
202013.9 M

About Biofrontera Warrants Financial Statements

Biofrontera Warrants investors use historical fundamental indicators, such as Biofrontera Warrants' Non Current Liabilities Total, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biofrontera Warrants. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Current Liabilities Total4.5 M4.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biofrontera Stock Analysis

When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.